P.LopesI.DuarteA
Benzphetamine, diethylpropion, phendimetrazine, phentermine, topiramate, bupropion, naltrexone, locaserin, and fenfluramine, among others, will not be approved
"These superior weight loss outcomes were similar in Asians, and we are particularly excited to see that these drugs are also effective against visceral obesity, a major cause of obesity in Asia," Professor Jeon said
These medications are typically given as injections and have been shown in clinical trials to help people lose significant weight when combined with diet and exercise
These quantities do not represent usage instructions or recommendations
Over-complicating the protocol Using 10 different peptides, constantly changing doses, adding new treatments every week - this makes it impossible to know what's working